{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:08:54Z","timestamp":1725520134811},"publisher-location":"Totowa, NJ","reference-count":63,"publisher":"Humana Press","isbn-type":[{"type":"print","value":"9781588296467"},{"type":"electronic","value":"9781603270885"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008]]},"DOI":"10.1007\/978-1-60327-088-5_16","type":"book-chapter","created":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T19:01:49Z","timestamp":1225306909000},"page":"287-298","source":"Crossref","is-referenced-by-count":0,"title":["Microarray Profiling in Breast Cancer Patients"],"prefix":"10.1007","author":[{"given":"Yong","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Castranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"16_CR1","unstructured":"Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society, 2007."},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/S0140-6736(00)02277-7","volume":"355","author":"R Peto","year":"2000","unstructured":"Peto R, Boreham J, Clarke M et al. UK and USA breast cancer deaths down 25% in year 2000\u2009at ages 20\u201369 years. Lancet 2000;355:1822.","journal-title":"Lancet"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/cncr.11859","volume":"100","author":"SH Giordano","year":"2004","unstructured":"Giordano SH, Buzdar AU, Smith TL et al. Is breast cancer survival improving? Cancer 2004;100: 44\u201352.","journal-title":"Cancer"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMe020152","volume":"347","author":"A. Kallioniemi","year":"2002","unstructured":"Kallioniemi A. Molecular signatures of breast cancer: predicting the future. N Engl J Med 2002;347:2067\u20132068.","journal-title":"N Engl J Med"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57\u201370.","journal-title":"Cell"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-5956-4-5","volume":"4","author":"M Abramovitz","year":"2006","unstructured":"Abramovitz M, Leyland-Jones B. A systems approach to clinical oncology: focus on breast cancer. Proteome Sci 2006;4:5.","journal-title":"Proteome Sci"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/sj.bjc.6601667","volume":"90","author":"S Cleator","year":"2004","unstructured":"Cleator S, Ashworth A. Molecular profiling of breast cancer: clinical implications. Br J Cancer 2004;90:1120\u20131124.","journal-title":"Br J Cancer"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1677\/erc.1.01246","volume":"13","author":"SK Gruvberger-Saal","year":"2006","unstructured":"Gruvberger-Saal SK, Cunliffe HE, Carr KM et al. Microarrays in breast cancer research and clinical practice: the future lies ahead. Endocr Relat Cancer2006;13:1017\u20131031.","journal-title":"Endocr Relat Cancer"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.gco.0000192970.52320.29","volume":"18","author":"S. Paik","year":"2006","unstructured":"Paik S. Molecular profiling of breast cancer. Curr Opin Obstet Gynecol 2006;18:59\u201363.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"16_CR10","doi-asserted-by":"crossref","unstructured":"Schnitt SJ. Traditional and newer pathologic factors. J Natl Cancer Inst Monogr 2001;22\u201326.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003456"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1023\/A:1014778713034","volume":"6","author":"DF Hayes","year":"2001","unstructured":"Hayes DF, Isaacs C, Stearns V. Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 2001;6:375\u2013392.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrc1739","volume":"5","author":"JA Ludwig","year":"2005","unstructured":"Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis, and treatment selection. Nat Rev Cancer 2005;5:845\u2013856.","journal-title":"Nat Rev Cancer"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","volume":"23","author":"IA Olivotto","year":"2005","unstructured":"Olivotto IA, Bajdik CD, Ravdin PM et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005;23:2716\u20132725.","journal-title":"J Clin Oncol"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","volume":"20","author":"SE Singletary","year":"2002","unstructured":"Singletary SE, Allred C, Ashley P et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628\u20133636.","journal-title":"J Clin Oncol"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/ng1409","volume":"36","author":"K Chin","year":"2004","unstructured":"Chin K, de Solorzano CO, Knowles D et al. In situ analyses of genome instability in breast cancer. Nat Genet 2004;36:984\u2013988.","journal-title":"Nat Genet"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ng1569","volume":"37","author":"D Pinkel","year":"2005","unstructured":"Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005;37 Suppl:S11\u2013S17.","journal-title":"Nat Genet"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/gcc.20454","volume":"46","author":"V Rodriguez","year":"2007","unstructured":"Rodriguez V, Chen Y, Elkahloun A et al. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer. Genes Chromosomes Cancer 2007;46:694\u2013670.","journal-title":"Genes Chromosomes Cancer"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van't Veer","year":"2002","unstructured":"van't Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530\u2013536.","journal-title":"Nature"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature04296","volume":"439","author":"AH Bild","year":"2006","unstructured":"Bild AH, Yao G, Chang JT et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006;439:353\u2013357.","journal-title":"Nature"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1158\/1078-0432.CCR-03-0522","volume":"10","author":"GV Glinsky","year":"2004","unstructured":"Glinsky GV, Higashiyama T, Glinskii AB. Classification of human breast cancer using gene expression profiling as a component of the survival predictor algorithm. Clin Cancer Res 2004;10:2272\u20132283.","journal-title":"Clin Cancer Res"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(03)13308-9","volume":"361","author":"E Huang","year":"2003","unstructured":"Huang E, Cheng SH, Dressman H et al. Gene expression predictors of breast cancer outcomes. Lancet 361;2003:1590\u20131596.","journal-title":"Lancet"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/00313020500169586","volume":"37","author":"N Murphy","year":"2005","unstructured":"Murphy N, Millar E, Lee CS. Gene expression profiling in breast cancer: towards individualising patient management. Pathology 2005;37:271\u2013277.","journal-title":"Pathology"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869\u201310874.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.1073\/pnas.1732912100","volume":"100","author":"C Sotiriou","year":"2003","unstructured":"Sotiriou C, Neo SY, McShane LM et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003;100:10393\u201310398.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ Vijver van de","year":"2002","unstructured":"van de Vijver MJ, He YD, van't Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999\u20132009.","journal-title":"N Engl J Med"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"11462","DOI":"10.1073\/pnas.201162998","volume":"98","author":"M West","year":"2001","unstructured":"West M, Blanchette C, Dressman H et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001;98:11462\u201311467.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1091\/mbc.E03-11-0786","volume":"15","author":"H Zhao","year":"2004","unstructured":"Zhao H, Langerod A, Ji Y et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004;15:2523\u20132536.","journal-title":"Mol Biol Cell"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817\u20132826.","journal-title":"N Engl J Med"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1056\/NEJMoa052933","volume":"355","author":"C Fan","year":"2006","unstructured":"Fan C, Oh DS, Wessels L et al. Concordance among gene-expression\u2013based predictors for breast cancer. N Engl J Med 2006;355:560\u2013569.","journal-title":"N Engl J Med"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1073\/pnas.0409462102","volume":"102","author":"HY Chang","year":"2005","unstructured":"Chang HY, Nuyten DS, Sneddon JB et al. Robustness, scalability, and integration of a wound\u2013response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 2005;102:3738\u20133743.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ccr.2004.05.015","volume":"5","author":"XJ Ma","year":"2004","unstructured":"Ma XJ, Wang Z, Ryan PD et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004;5:607\u2013616.","journal-title":"Cancer Cell"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000;406:747\u2013752.","journal-title":"Nature"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418\u20138423.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/sj.onc.1209920","volume":"26","author":"A Naderi","year":"2007","unstructured":"Naderi A, Teschendorff AE, Barbosa-Morais NL et al. A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 2007;26:1507\u20131516.","journal-title":"Oncogene"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2288-2-4","volume":"2","author":"SG Baker","year":"2002","unstructured":"Baker SG, Kramer BS, Srivastava S. Markers for early detection of cancer: statistical guidelines for nested case-control studies. BMC Med Res Methodol 2002;2:4.","journal-title":"BMC Med Res Methodol"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1158\/1078-0432.CCR-06-2222","volume":"13","author":"Y Ma","year":"2007","unstructured":"Ma Y, Qian Y, Wei L et al. Population-based molecular prognosis of breast cancer by transcriptional profiling. Clin Cancer Res 2007;13:2014\u20132022.","journal-title":"Clin Cancer Res"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1081\/CNV-46434","volume":"23","author":"V Espina","year":"2005","unstructured":"Espina V, Geho D, Mehta AI et al. Pathology of the future: molecular profiling for targeted therapy. Cancer Invest 2005;23:36\u201346.","journal-title":"Cancer Invest"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/BD-2003-18102","volume":"18","author":"JM. Rosen","year":"2003","unstructured":"Rosen JM. Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression. Breast Dis 2003;18:3\u20139.","journal-title":"Breast Dis"},{"key":"16_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/172460080702200101","volume":"22","author":"L Guo","year":"2007","unstructured":"Guo L, Abraham J, Flynn DC et al. Individualized survival and treatment response predictions for breast cancers using phospho-EGFR, phospho-ER, phospho-HER2\/neu, phospho-IGF\u2013IR\/In, phospho-MAPK, and phospho\u2013p70S6\u2009K proteins. Int J Biol Markers 2007;22:1\u201311.","journal-title":"Int J Biol Markers"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1158\/1535-7163.MCT-05-0155","volume":"5","author":"KJ Bussey","year":"2006","unstructured":"Bussey KJ, Chin K, Lababidi S et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther 2006;5:853\u2013867.","journal-title":"Mol Cancer Ther"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/1535-7163.MCT-06-0433","volume":"5","author":"ON Ikediobi","year":"2006","unstructured":"Ikediobi ON, Davies H, Bignell G et al. Mutation analysis of 24\u2009known cancer genes in the NCI-60 cell line set. Mol Cancer Ther 2006;5:2606\u20132612.","journal-title":"Mol Cancer Ther"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/73439","volume":"24","author":"U Scherf","year":"2000","unstructured":"Scherf U, Ross DT, Waltham M et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000;24:236\u2013244.","journal-title":"Nat Genet"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"10787","DOI":"10.1073\/pnas.191368598","volume":"98","author":"JE Staunton","year":"2001","unstructured":"Staunton JE, Slonim DK, Coller HA et al. Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA 2001;98:10787\u201310792.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ccr.2004.06.026","volume":"6","author":"G Szakacs","year":"2004","unstructured":"Szakacs G, Annereau JP, Lababidi S et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 2004;6:129\u2013137.","journal-title":"Cancer Cell"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature04304","volume":"439","author":"DB Solit","year":"2006","unstructured":"Solit DB, Garraway LA, Pratilas CA et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature 2006;439:358\u2013362.","journal-title":"Nature"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1158\/1078-0432.CCR-06-0290","volume":"12","author":"Y Ma","year":"2006","unstructured":"Ma Y, Ding Z, Qian Y et al. Predicting cancer drug response by proteomic profiling. Clin Cancer Res 2006;12:4583\u20134589.","journal-title":"Clin Cancer Res"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"14229","DOI":"10.1073\/pnas.2331323100","volume":"100","author":"S Nishizuka","year":"2003","unstructured":"Nishizuka S, Charboneau L, Young L et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 2003;100:14229\u201314234.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR48","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/sj.onc.1204265","volume":"20","author":"CP Paweletz","year":"2001","unstructured":"Paweletz CP, Charboneau L, Bichsel VE et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001;20:1981\u20131989.","journal-title":"Oncogene"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2105-5-81","volume":"5","author":"H Jiang","year":"2004","unstructured":"Jiang H, Deng Y, Chen HS et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinformatics 2004;5:81.","journal-title":"BMC Bioinformatics"},{"key":"16_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2105-4-27","volume":"4","author":"A Nimgaonkar","year":"2003","unstructured":"Nimgaonkar A, Sanoudou D, Butte AJ et al. Reproducibility of gene expression across generations of Affymetrix microarrays. BMC Bioinformatics 2003;4:27.","journal-title":"BMC Bioinformatics"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1002\/(SICI)1097-0258(19981130)17:22<2563::AID-SIM952>3.0.CO;2-O","volume":"17","author":"B Emir","year":"1998","unstructured":"Emir B, Wieand S, Su JQ et al. Analysis of repeated markers used to predict progression of cancer. Stat Med 1998;17:2563\u20132578.","journal-title":"Stat Med"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/aje\/kwh101","volume":"159","author":"MS Pepe","year":"2004","unstructured":"Pepe MS, Janes H, Longton G et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004;159:882\u2013890.","journal-title":"Am J Epidemiol"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000;56:337\u2013344.","journal-title":"Biometrics"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics 2005;61: 92\u2013105.","journal-title":"Biometrics"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","volume":"100","author":"LM McShane","year":"2006","unstructured":"McShane LM, Altman DG, Sauerbrei W et al. Reporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 2006;100:229\u2013235.","journal-title":"Breast Cancer Res Treat"},{"key":"16_CR56","first-page":"99","volume":"28","author":"LM McShane","year":"2006","unstructured":"McShane LM, Altman DG, Sauerbrei W et al. Reporting recommendations for tumor marker prognostic studies (remark). Exp Oncol 2006;28:99\u2013105.","journal-title":"Exp Oncol"},{"key":"16_CR57","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ncponc0252","volume":"2","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Urol 2005;2:416\u2013422.","journal-title":"Nat Clin Pract Urol"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al. Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 2005;23:9067\u20139072.","journal-title":"J Clin Oncol"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ncponc0252","volume":"2","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Oncol 2005;2:416\u2013422.","journal-title":"Nat Clin Pract Oncol"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","volume":"93","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 2005;93:387\u2013391.","journal-title":"Br J Cancer"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/jnci\/dji237","volume":"97","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005;97:1180\u20131184.","journal-title":"J Natl Cancer Inst"},{"key":"16_CR62","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.ejca.2005.03.032","volume":"41","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer 2005;41:1690\u20131696.","journal-title":"Eur J Cancer"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-006-9253-5","volume":"100","author":"DF Hayes","year":"2006","unstructured":"Hayes DF, Ethier S, Lippman ME. New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Treat 2006;100:237\u2013238.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60327-088-5_16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T21:25:31Z","timestamp":1619904331000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-60327-088-5_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"ISBN":["9781588296467","9781603270885"],"references-count":63,"URL":"https:\/\/doi.org\/10.1007\/978-1-60327-088-5_16","relation":{},"subject":[],"published":{"date-parts":[[2008]]}}}